家禽疫苗市場 - 全球產業規模、佔有率、趨勢、機會和預測，2018-2028按應用、按產品、按疾病類型、按地區、按競爭預測和機會細分，2018-2028F

2022 年，全球家禽疫苗市場價值為17.3 億美元，預計到2028 年，預測期內將出現令人矚目的成長，年複合成長率為6.90%。全球家禽疫苗市場是全球動物保健行業中充滿活力且重要的部分。該市場主要圍繞著疫苗的開發、生產和分銷，旨在保護家禽（包括雞和火雞）免受一系列疾病的侵害。家禽養殖是全球食品供應鏈的重要組成部分，因此有效疫苗的供應對於維持家禽群的健康和生產力至關重要。

主要市場促進因素

全球家禽消費量上升

市場概況
預測期	2024-2028
2022 年市場規模	17.3億美元
2028 年市場規模	26億美元
2023-2028 年年複合成長率	6.90%
成長最快的細分市場	減毒活疫苗
最大的市場	北美洲

由於全球對雞肉和火雞等家禽產品的需求不斷成長，全球家禽業正在飆升至新的高度。人們對家禽的需求不斷成長，不僅證明了飲食偏好的變化，也是全球家禽疫苗市場擴張的主要動力。家禽，尤其是雞肉，因其價格實惠、用途廣泛和瘦肉蛋白含量而成為全世界飲食的主食。隨著全球人口激增和城市化進程的持續，對家禽產品的需求激增。據業界報告稱，家禽消費呈穩定上升趨勢，沒有放緩的跡象。需求的激增與健康和永續的家禽業的需求直接相關。家禽業不僅是蛋白質的重要來源，也是全球經濟的重要貢獻者。然而，它極易受到疾病爆發的影響，導致家禽大量死亡、供應鏈中斷並造成重大經濟損失。禽流感、新城疫和球蟲病等疾病對家禽養殖場構成持續威脅。因此，保障家禽健康已成為該產業持續成長的當務之急。家禽疫苗是預防和管理疾病爆發的基本工具。它們提供了一種經濟高效且人道的方式來保護家禽群免受各種疾病的侵害。透過給禽類接種疫苗，農民可以降低發病率和死亡率，確保家禽產品的持續健康供應。疫苗在預防疾病爆發方面的可靠性是其在家禽業中越來越多採用的驅動力。隨著全球家禽消費量持續成長，家禽養殖戶和生產者越來越意識到疾病預防的重要性。為了滿足對家禽產品不斷成長的需求並降低疾病爆發的風險，農民擴大實施疫苗接種計劃。這些計劃涉及在家禽生命週期的各個階段對其進行疫苗接種，以增強其免疫力和整體健康。家禽消費的激增促使家禽疫苗產業對研發進行了大量投資。公司正致力於開發更有效和創新的疫苗來對抗更廣泛的疾病。這些進步包括新型疫苗配方、改進的遞送方法以及針對當地疾病特徵量身定做的區域特異性疫苗。

預防家禽動物疾病爆發

全球家禽業正面臨前所未有的挑戰，因為它努力滿足對家禽產品不斷成長的需求。家禽群中疾病爆發可能是災難性的，導致重大經濟損失和供應鏈中斷。為了應對這項威脅，全球家禽疫苗市場已成為保障家禽健康的關鍵參與者。家禽，包括雞和火雞，非常容易感染一系列疾病，包括禽流感、新城疫、傳染性支氣管炎和球蟲病。這些疾病可在雞群內迅速傳播，導致死亡率上升、生產效率下降，並為家禽養殖戶帶來巨大的經濟損失。預防這些疾病對於確保家禽的健康和生產力至關重要。家禽疫苗是預防和管理家禽疾病爆發的關鍵工具。這些疫苗經過專門配製，可以刺激鳥類的免疫系統，使其能夠抵抗病原體。透過給家禽動物接種疫苗，農民可以降低疾病傳播的風險，並將疫情的影響降至最低，從而使雞群更健康，家禽產品供應更可靠。家禽疾病爆發的經濟影響是深遠的。損失不僅包括鳥類死亡的直接成本，還包括與疾病控制措施相關的費用，例如增加的藥物使用、檢疫程序和額外的勞動成本。此外，供應鏈的中斷可能導致價格波動和市場上家禽產品的供應量減少。農民和家禽生產者越來越認知到疫苗接種計劃在預防疾病爆發方面的價值。這些計劃涉及對處於生命週期各個階段的家禽群進行系統性疫苗接種。隨著人們對疾病預防重要性的認知不斷增強，越來越多的農民開始投資疫苗接種計劃，作為保護其投資並確保家禽產品持續供應的主動策略。全球家禽業正在擴張，特別是在新興市場，城市化、收入增加和飲食習慣的改變正在推動家禽消費的增加。隨著家禽業的發展，有效的疾病預防策略的需求也在增加。家禽疫苗是這些策略的組成部分，有助於產業的整體健康和永續發展。

疫苗技術的進步

全球家禽疫苗市場正在經歷重大轉變，這在很大程度上是由疫苗技術突破性進步所推動的。家禽養殖是食品工業的基石，面臨著疾病爆發和滿足世界對家禽產品不斷成長的需求的日益嚴峻的挑戰。疫苗技術進步最顯著的好處之一是家禽疫苗效力的增強。傳統疫苗已被更複雜的配方所取代，這些配方可以用更少的劑量提供更持久的保護。這些新一代疫苗可刺激家禽更強、更持久的免疫反應，降低疾病爆發的可能性並改善雞群的整體健康。現代疫苗技術可以開發針對特定疾病或病原體菌株的高度特異性疫苗。這種精確度對於解決影響家禽的各種疾病至關重要。透過針對特定病原體，疫苗可以更好地預防更廣泛的疾病，包括禽流感、新城疫和球蟲病。疫苗輸送方法的進步使家禽養殖戶的疫苗接種變得更加方便和有效率。傳統的注射疫苗正在接受口服疫苗、霧化疫苗和載有疫苗的誘餌等創新方法的補充。這些方法簡化了疫苗管理，減少了對鳥類的壓力，並最大限度地減少了對熟練勞動力的需求，有助於節省成本和提高採用率。新的疫苗技術旨在更有效地刺激鳥類的免疫系統。佐劑和輸送系統經過改進，可引發強大且持續的免疫反應。這可確保家禽對疾病產生強大的免疫力，從而減少與疾病相關的損失並提高雞群的生產力。為了應對特定區域的疾病挑戰，疫苗製造商正在開發客製化的區域疫苗。這些疫苗考慮了特定地理區域的流行疾病和病毒株，為家禽養殖戶提供針對其獨特疾病特徵的客製化解決方案。這種客製化可以實現更有效的疾病預防策略。

擴大新興市場的家禽業

全球家禽業正在經歷顯著的擴張，其中大部分成長是由亞太、拉丁美洲和非洲等地區的新興市場所推動的。隨著這些市場家禽生產和消費的激增，對有效疾病預防措施，特別是家禽疫苗的需求不斷增加。由於快速城市化、可支配收入增加和飲食偏好變化等因素，新興經濟體正成為全球家禽業的關鍵參與者。這些地區正在經歷對雞肉和火雞等富含蛋白質的家禽產品的更高消費的轉變。因此，新興市場正穩步崛起，成為全球家禽業的主要貢獻者。新興市場不斷擴大的家禽業的特徵是家禽產量大幅增加。家禽養殖場的規模和複雜性不斷擴大，採用了現代農業實踐和技術。為了滿足對家禽產品不斷成長的需求，這些農場正在管理更大的雞群，這反過來又增加了疾病爆發的可能性。新興市場家禽業的快速成長伴隨著新的和不斷變化的疾病挑戰。禽流感、新城疫、球蟲病等家禽疾病對家禽健康及生產有重大威脅。這些疾病可以在人口密集的家禽養殖場中迅速傳播，導致嚴重的經濟損失和潛在的糧食安全問題。家禽疫苗是預防和管理家禽疾病爆發不可或缺的工具。它們提供了一種經濟高效且人道的方法來保護家禽免受多種疾病的侵害。隨著新興市場努力應對因家禽生產集約化而增加的疾病風險，疫苗在維持雞群健康和確保糧食供應方面的重要性怎麼強調也不為過。

主要市場挑戰

疾病的複雜性和變異性

家禽疫苗市場面臨的最重要挑戰之一是家禽疾病的複雜性和變異性。家禽容易受到多種病原體的影響，包括病毒、細菌和寄生蟲，每種病原體都有不同的菌株和突變。開發針對這些不斷進化的病原體提供全面保護的疫苗可能是一項艱鉅的任務。

監管障礙

疫苗的生產和分銷須遵守嚴格的監管要求，以確保安全性和有效性。對於疫苗製造商來說，滿足這些監管標準可能是一個成本高昂且耗時的過程。任何偏離這些標準的行為都可能導致疫苗批准和市場准入的延遲，從而增加財務負擔。

冷鏈管理

在整個分配過程中保持疫苗的完整性至關重要。家禽疫苗通常對溫度波動敏感，儲存不當可能會使其失效。在基礎設施和資源有限的地區，維持可靠的疫苗冷鏈可能是一項重大挑戰。

疫苗抗藥性和合規性

疫苗抗藥性，即病原體對疫苗產生抗藥性，越來越受到人們的關注。此外，確保家禽養殖戶遵守建議的疫苗接種時間表和方案可能具有挑戰性。疫苗接種不一致可能會導致保護缺口和疾病爆發。

主要市場趨勢

精準疫苗接種

精準疫苗接種是家禽疫苗市場的發展趨勢。這種方法涉及根據個體雞群或禽舍的具體需求量身定做疫苗接種計劃。透過考慮年齡、健康狀況和疾病暴露等因素，精準疫苗接種旨在最佳化疫苗功效，同時最大限度地降低成本。先進的資料分析和監測系統被用來有效實施精準疫苗接種策略。

免疫增強佐劑

疫苗佐劑的創新即將到來。佐劑是一種添加到疫苗中以增強人體免疫反應的物質。新型佐劑的開發可以提高家禽疫苗的功效，從而更好地預防更廣泛的疾病。這些佐劑還可以減少多次加強疫苗接種的需要，提高疫苗接種計畫的便利性和成本效益。

DNA疫苗

DNA 疫苗因其在家禽疫苗市場的潛力而受到關注。這些疫苗使用遺傳物質 (DNA) 來刺激免疫系統。 DNA疫苗因其安全性、穩定性和快速開發潛力而具有優勢。隨著該領域研究的進展，DNA 疫苗可能成為家禽疾病傳統疫苗的可行替代品。

疫苗輸送創新

疫苗輸送系統的進步將徹底改變家禽疫苗市場。除了傳統的注射疫苗外，口服疫苗、霧化疫苗和載有疫苗的誘餌等新型遞送方法也正在開發中。這些方法簡化了疫苗接種，減輕了鳥類的壓力，並提高了疫苗接種計畫的效率。

細分市場洞察

產品洞察

2022年，減毒活疫苗類別佔據了收入的最大部分。與其他疫苗品種相比，這些類型的疫苗能夠刺激免疫系統產生更多數量的抗體。此外，它們的保護作用持續時間更長，可以預防傳染性支氣管炎、傳染性法氏囊病和新城疫等禽類疾病。此外，為對抗上述疾病的爆發，特別是在疫苗接種領域，不斷增加的研發力度也推動了這一領域的成長。

疾病類型見解

2022年，與沙門氏菌疾病相關的業務佔收入的最大部分。在預測期內，掉蛋綜合症（EDS）領域預計將表現出最快的年複合成長率（CAGR）。這種成長可歸因於家禽中沙門氏菌和產蛋綜合症疾病的高流行。沙門氏菌疫苗的主要類型包括減毒沙門氏菌菌株，它們作為口服載體疫苗有效且安全地發揮作用，透過表達外源抗原來預防壞死性腸炎。

市場參與者積極參與新疫苗的研發工作，旨在擴大其影響力和市場佔有率。例如，Venkys India 提供一系列家禽疫苗，包括沙門氏菌多價去活化疫苗，旨在預防和控制蛋雞、種雞和肉雞的沙門氏菌病。 KM Biologics 的產品組合中包含 OILVAX EDS-76，可有效對抗掉蛋症候群。

區域洞察

2022年，歐洲在收入佔有率方面佔據主導地位。這可以歸因於多種因素，包括主要行業參與者的存在、不斷努力打擊在動物中使用抗菌劑以及對人畜共患疾病的擔憂不斷升級。世界衛生組織 (WHO) 已將抗菌素抗藥性視為重大的公共衛生風險。各種公共衛生組織和獸醫監管機構，例如獸醫用藥品委員會 (CVMP)，負責實施歐盟統一健康行動計劃，以解決抗菌素抗藥性問題。他們透過制定《獸藥條例》中概述的政策來做到這一點。

另一方面，亞太地區預計在預測期內年複合成長率最快。這可以歸因於人們對家禽疫苗的認知不斷提高、疫苗接種意識計劃的激增以及其他因素，例如政府舉措的加強和畜牧業實踐的顯著進步。

目錄

第 1 章：產品概述

• 市場定義
• 市場範圍
  • 涵蓋的市場
  • 研究年份
  • 主要市場區隔

第 2 章：研究方法

• 研究目的
• 基線方法
• 主要產業夥伴
• 主要協會和二手資料來源
• 預測方法
• 數據三角測量與驗證
• 假設和限制

第 3 章：執行摘要

• 市場概況
• 主要市場細分概述
• 主要市場參與者概述
• 重點地區/國家概況
• 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球家禽疫苗市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按應用（肉雞、蛋雞、種雞）
  • 依產品（減毒活疫苗、不活化疫苗、次單位疫苗、DNA疫苗、重組疫苗）
  • 依疾病類型（傳染性支氣管炎、傳染性法氏囊病、傳染性喉氣管炎、滴蛋症候群、腺病毒、鴨病毒性腸炎、包涵體肝炎、沙門氏菌等）
  • 按地區
  • 按公司分類 (2022)
• 產品市場地圖
  • 按應用
  • 按產品分類
  • 依疾病類型
  • 按地區

第 6 章：北美家禽疫苗市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按應用（肉雞、蛋雞、種雞）
  • 依產品（減毒活疫苗、不活化疫苗、次單位疫苗、DNA疫苗、重組疫苗）
  • 依疾病類型（傳染性支氣管炎、傳染性法氏囊病、傳染性喉氣管炎、滴蛋症候群、腺病毒、鴨病毒性腸炎、包涵體肝炎、沙門氏菌等）
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第 7 章：歐洲家禽疫苗市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按應用（肉雞、蛋雞、種雞）
  • 依產品（減毒活疫苗、不活化疫苗、次單位疫苗、DNA疫苗、重組疫苗）
  • 依疾病類型（傳染性支氣管炎、傳染性法氏囊病、傳染性喉氣管炎、滴蛋症候群、腺病毒、鴨病毒性腸炎、包涵體肝炎、沙門氏菌等）
  • 按國家/地區
• 歐洲：國家分析
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙

第 8 章：亞太地區家禽疫苗市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按應用（肉雞、蛋雞、種雞）
  • 依產品（減毒活疫苗、不活化疫苗、次單位疫苗、DNA疫苗、重組疫苗）
  • 依疾病類型（傳染性支氣管炎、傳染性法氏囊病、傳染性喉氣管炎、滴蛋症候群、腺病毒、鴨病毒性腸炎、包涵體肝炎、沙門氏菌等）
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國

第 9 章：南美洲家禽疫苗市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按應用（肉雞、蛋雞、種雞）
  • 依產品（減毒活疫苗、不活化疫苗、次單位疫苗、DNA疫苗、重組疫苗）
  • 依疾病類型（傳染性支氣管炎、傳染性法氏囊病、傳染性喉氣管炎、滴蛋症候群、腺病毒、鴨病毒性腸炎、包涵體肝炎、沙門氏菌等）
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲家禽疫苗市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按應用（肉雞、蛋雞、種雞）
  • 依產品（減毒活疫苗、不活化疫苗、次單位疫苗、DNA疫苗、重組疫苗）
  • 依疾病類型（傳染性支氣管炎、傳染性法氏囊病、傳染性喉氣管炎、滴蛋症候群、腺病毒、鴨病毒性腸炎、包涵體肝炎、沙門氏菌等）
  • 按國家/地區
• MEA：國家分析
  • 南非家禽疫苗
  • 沙烏地阿拉伯家禽疫苗
  • 阿拉伯聯合大公國家禽疫苗
  • 科威特家禽疫苗

第 11 章：市場動態

• 促進要素
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第14章：競爭格局

• 商業概覽
• 產品供應
• 最近的發展
• 財務（據報導）
• 主要人員
• SWOT分析
  • Boehringer Ingelheim GmbH
  • Zoetis Inc
  • Elanco LLC
  • Intervet Inc
  • Hester Biosciences Ltd
  • Vaxxinova GmbH
  • Venky's India Ltd
  • Laboratorios Calier SA
  • KM Biologics Co Ltd
  • Phibro Animal Health Corp

第 15 章：策略建議

第 16 章：關於我們與免責聲明

Global Poultry Vaccines Market has valued at USD 1.73 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.90% through 2028. The Global Poultry Vaccines Market is a dynamic and essential segment of the global animal healthcare industry. This market primarily revolves around the development, production, and distribution of vaccines designed to safeguard poultry, including chickens and turkeys, from a range of diseases. Poultry farming is a critical component of the global food supply chain, making the availability of effective vaccines crucial for maintaining the health and productivity of poultry flocks.

Key Market Drivers

Rising Global Poultry Consumption

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 1.73 Billion
Market Size 2028	USD 2.60 Billion
CAGR 2023-2028	6.90%
Fastest Growing Segment	Attenuated Live Vaccine
Largest Market	North America

The global poultry industry is soaring to new heights, fueled by an ever-increasing global demand for poultry products such as chicken and turkey. This growing appetite for poultry is not only a testament to shifting dietary preferences but also a major driver for the expansion of the global poultry vaccines market. Poultry, particularly chicken, has become a staple in diets worldwide due to its affordability, versatility, and lean protein content. As global populations burgeon and urbanization continues, the demand for poultry products has surged. According to industry reports, poultry consumption is on a steady upward trajectory, with no signs of slowing down. This surge in demand directly correlates with the need for a healthy and sustainable poultry industry. The poultry industry is not only a vital source of protein but also a significant contributor to the global economy. However, it is highly susceptible to disease outbreaks that can decimate poultry flocks, disrupt supply chains, and incur substantial economic losses. Diseases such as avian influenza, Newcastle disease, and coccidiosis pose constant threats to poultry farms. Consequently, safeguarding poultry health has become imperative for the industry's sustained growth. Poultry vaccines are a fundamental tool in preventing and managing disease outbreaks. They offer a cost-effective and humane way to protect poultry flocks from various diseases. By vaccinating birds, farmers can reduce the morbidity and mortality rates, ensuring a consistent and healthy supply of poultry products. The reliability of vaccines in preventing disease outbreaks is a driving force behind their increasing adoption in the poultry industry. As global poultry consumption continues to rise, poultry farmers and producers are becoming more conscious of the importance of disease prevention. To meet the growing demand for poultry products and mitigate the risk of disease outbreaks, farmers are increasingly implementing vaccination programs. These programs involve the administration of vaccines to poultry flocks at various stages of their lifecycle, bolstering their immunity and overall health. The surge in poultry consumption has prompted significant investments in research and development within the poultry vaccines industry. Companies are focusing on developing more efficacious and innovative vaccines to combat a broader spectrum of diseases. These advancements include novel vaccine formulations, improved delivery methods, and region-specific vaccines tailored to local disease profiles.

Preventing Disease Outbreaks in Poultry Animals

The global poultry industry is facing unprecedented challenges as it strives to meet the ever-growing demand for poultry products. Disease outbreaks in poultry flocks can be catastrophic, resulting in significant economic losses and disruptions to the supply chain. In response to this threat, the global poultry vaccines market has emerged as a crucial player in safeguarding poultry health. Poultry, including chickens and turkeys, are highly susceptible to a range of diseases, including avian influenza, Newcastle disease, infectious bronchitis, and coccidiosis. These diseases can spread rapidly within flocks, leading to increased mortality rates, decreased production efficiency, and substantial financial losses for poultry farmers. Preventing these diseases is paramount to ensuring the health and productivity of poultry animals. Poultry vaccines are pivotal tools in preventing and managing disease outbreaks in poultry populations. These vaccines are specifically formulated to stimulate the bird's immune system, equipping them to fend off pathogens. By vaccinating poultry animals, farmers can reduce the risk of disease transmission and minimize the impact of outbreaks, resulting in healthier flocks and a more reliable supply of poultry products. The economic ramifications of disease outbreaks in poultry are profound. Losses can encompass not only the direct costs of bird mortality but also the expenses associated with disease control measures, such as increased medication usage, quarantine procedures, and additional labor costs. Moreover, the disruption in the supply chain can lead to price fluctuations and reduced availability of poultry products in the market. Farmers and poultry producers are increasingly recognizing the value of vaccination programs in preventing disease outbreaks. These programs involve the systematic administration of vaccines to poultry flocks at various stages of their lifecycle. As awareness of the importance of disease prevention grows, more farmers are investing in vaccination programs as a proactive strategy to protect their investments and ensure a consistent supply of poultry products. The global poultry industry is expanding, particularly in emerging markets where urbanization, rising incomes, and changing dietary habits are driving increased poultry consumption. As the poultry industry grows, so does the need for effective disease prevention strategies. Poultry vaccines are an integral part of these strategies, contributing to the overall health and sustainability of the industry.

Advancements in Vaccine Technology

The global poultry vaccines market is undergoing a significant transformation, driven in large part by groundbreaking advancements in vaccine technology. Poultry farming, a cornerstone of the food industry, faces ever-increasing challenges from disease outbreaks and the need to meet the world's growing demand for poultry products. One of the most notable benefits of advancements in vaccine technology is the enhanced efficacy of poultry vaccines. Traditional vaccines have given way to more sophisticated formulations that can provide longer-lasting protection with fewer doses. These next-generation vaccines stimulate a stronger and more sustained immune response in poultry, reducing the likelihood of disease outbreaks and improving overall flock health. Modern vaccine technology allows for the development of highly specific vaccines tailored to target particular diseases or strains of pathogens. This level of precision is essential in addressing the diverse range of diseases that affect poultry. By targeting specific pathogens, vaccines can offer better protection against a broader spectrum of diseases, including avian influenza, Newcastle disease, and coccidiosis. Advancements in vaccine delivery methods have made vaccination more convenient and efficient for poultry farmers. Traditional injection-based vaccines are being complemented by innovative approaches such as oral vaccines, aerosolized vaccines, and vaccine-laden bait. These methods simplify vaccine administration, reduce stress on birds, and minimize the need for skilled labor, contributing to cost savings and increased adoption rates. New vaccine technologies are designed to stimulate the bird's immune system more effectively. Adjuvants and delivery systems have been refined to trigger a robust and sustained immune response. This ensures that poultry develop strong immunity to diseases, resulting in fewer disease-related losses and more productive flocks. To address region-specific disease challenges, vaccine manufacturers are developing customized regional vaccines. These vaccines take into account the prevalent diseases and strains in a specific geographic area, providing poultry farmers with tailored solutions for their unique disease profiles. This customization allows for more effective disease prevention strategies.

Expanding Poultry Industry in Emerging Markets

The global poultry industry is experiencing a remarkable expansion, and much of this growth is driven by emerging markets in regions like Asia-Pacific, Latin America, and Africa. As these markets witness a surge in poultry production and consumption, the demand for effective disease prevention measures, particularly poultry vaccines, is on the rise. Emerging economies are becoming key players in the global poultry industry due to factors such as rapid urbanization, increasing disposable incomes, and changing dietary preferences. These regions are experiencing a shift towards a higher consumption of protein-rich poultry products like chicken and turkey. As a result, emerging markets are steadily emerging as major contributors to the global poultry industry. The expanding poultry industry in emerging markets is characterized by substantial increases in poultry production. Poultry farms are growing in size and sophistication, adopting modern farming practices and technology. With the goal of meeting the rising demand for poultry products, these farms are managing larger flocks, which in turn increases the potential for disease outbreaks. The rapid growth of the poultry industry in emerging markets is accompanied by new and evolving disease challenges. Poultry diseases, such as avian influenza, Newcastle disease, and coccidiosis, pose significant threats to poultry health and production. These diseases can spread rapidly within densely populated poultry farms, leading to severe economic losses and potential food security concerns. Poultry vaccines are indispensable tools in preventing and managing disease outbreaks in poultry flocks. They offer a cost-effective and humane means of protecting poultry from a wide range of diseases. As emerging markets grapple with increased disease risks due to intensified poultry production, the importance of vaccines in maintaining flock health and securing food supplies cannot be overstated.

Key Market Challenges

Disease Complexity and Variability

One of the foremost challenges in the poultry vaccines market is the complexity and variability of poultry diseases. Poultry are susceptible to a wide range of pathogens, including viruses, bacteria, and parasites, each with different strains and mutations. Developing vaccines that provide comprehensive protection against these evolving pathogens can be a formidable task.

Regulatory Hurdles

The production and distribution of vaccines are subject to stringent regulatory requirements to ensure safety and efficacy. Meeting these regulatory standards can be a costly and time-consuming process for vaccine manufacturers. Any deviations from these standards can lead to delays in vaccine approval and market entry, increasing the financial burden.

Cold Chain Management

Maintaining the integrity of vaccines throughout the distribution process is critical. Poultry vaccines are often sensitive to temperature fluctuations, and improper storage can render them ineffective. In regions with limited infrastructure and resources, maintaining a reliable cold chain for vaccines can be a significant challenge.

Vaccine Resistance and Compliance

Vaccine resistance, where pathogens develop resistance to vaccines, is a growing concern. Additionally, ensuring that poultry farmers adhere to recommended vaccination schedules and protocols can be challenging. Inconsistent vaccine administration can lead to gaps in protection and disease outbreaks.

Key Market Trends

Precision Vaccination

Precision vaccination is a trend gaining momentum in the poultry vaccines market. This approach involves tailoring vaccination programs to the specific needs of individual flocks or poultry houses. By considering factors such as age, health status, and disease exposure, precision vaccination aims to optimize vaccine efficacy while minimizing costs. Advanced data analytics and monitoring systems are being employed to implement precision vaccination strategies effectively.

Immune-Boosting Adjuvants

Innovations in vaccine adjuvants are on the horizon. Adjuvants are substances added to vaccines to enhance the body's immune response. The development of novel adjuvants can improve the efficacy of poultry vaccines, enabling better protection against a wider range of diseases. These adjuvants may also reduce the need for multiple booster vaccinations, enhancing the convenience and cost-effectiveness of vaccination programs.

DNA Vaccines

DNA vaccines are gaining attention for their potential in the poultry vaccines market. These vaccines use genetic material (DNA) to stimulate the immune system. DNA vaccines are advantageous due to their safety, stability, and potential for rapid development. As research in this area progresses, DNA vaccines may become a viable alternative to traditional vaccines for poultry diseases.

Vaccine Delivery Innovations

Advancements in vaccine delivery systems are set to revolutionize the poultry vaccines market. In addition to traditional injection-based vaccines, novel delivery methods such as oral vaccines, aerosolized vaccines, and vaccine-laden bait are being developed. These methods simplify vaccine administration, reduce stress on birds, and increase the efficiency of vaccination programs.

Segmental Insights

Product Insights

In 2022, the category of attenuated live vaccines secured the largest portion of revenue. These types of vaccines are capable of stimulating the immune system to generate a higher quantity of antibodies compared to other vaccine varieties. Additionally, their protective effects last longer and guard against avian illnesses like infectious bronchitis, infectious bursal disease, and Newcastle disease. Furthermore, the growth of this segment is being boosted by the increasing research and development efforts, particularly in the field of vaccination, to combat outbreaks of the mentioned diseases.

In the upcoming years, the segments of recombinant vaccines and inactivated vaccines are expected to experience rapid growth. This is primarily driven by advancements in product development and the safety advantages offered by inactivated and recombinant vaccines when compared to live attenuated vaccines. For instance, Zoetis has an extensive range of poultry vaccines in its Poulvac brand, with poultry accounting for 18% of the company's livestock revenue in 2020.

Disease Type Insights

In 2022, the segment related to salmonella diseases accounted for the largest portion of revenue. Over the forecast period, the Egg Drop Syndrome (EDS) segment is anticipated to exhibit the most rapid Compound Annual Growth Rate (CAGR). This growth can be attributed to the high prevalence of Salmonella and Egg Drop Syndrome diseases among poultry animals. The predominant type of vaccine for salmonella consists of attenuated Salmonella strains, which function effectively and safely as oral carrier vaccines for preventing necrotic enteritis by expressing foreign antigens.

Market participants are actively engaged in research and development efforts to introduce new vaccines, aiming to expand their presence and market share. For instance, Venkys India offers a range of poultry vaccines, including the Salmonella polyvalent inactivated vaccine, designed to prevent and manage salmonellosis in layers, breeders, and broilers. KM Biologics includes OILVAX EDS-76 in its portfolio, which effectively combats egg drop syndrome.

Regional Insights

In 2022, Europe dominated in terms of revenue share. This can be attributed to several factors, including the presence of major industry players, growing efforts to combat the use of antimicrobial agents in animals, and escalating concerns about zoonotic diseases. The World Health Organization (WHO) has recognized antimicrobial resistance as a significant public health risk. Various public health organizations and veterinary regulatory bodies, such as the Committee for Medicinal Products for Veterinary Use (CVMP), are responsible for implementing the EU's One Health Action Plan to address antimicrobial resistance. They do this by enacting policies outlined in the Veterinary Medicines Regulation.

On the other hand, the Asia Pacific region is projected to experience the most rapid CAGR during the forecast period. This can be attributed to the increasing awareness about poultry vaccines, a surge in vaccination awareness programs, and other factors such as heightened government initiatives and notable advancements in animal husbandry practices.

Key Market Players

• Boehringer Ingelheim GmbH

• Zoetis Inc

• Elanco LLC

• Intervet Inc

• Hester Biosciences Ltd

• Vaxxinova GmbH

• Venky's India Ltd

• Laboratorios Calier SA

• KM Biologics Co Ltd

• Phibro Animal Health Corp

Report Scope:

In this report, the Global Poultry Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Vaccines Market, By Application:

• Broiler
• Layer
• Breeder

Poultry Vaccines Market, By Product:

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Poultry Vaccines Market, By Disease Type:

• Infectious Bronchitis
• Infectious Bursal Diseases
• Infectious Laryngotracheitis
• Egg Drop Syndrome
• Adenovirus
• Duck Viral Enteritis
• Inclusion Body Hepatitis
• Salmonella
• Others

Poultry Vaccines Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Poultry Vaccines Market.

Available Customizations:

• Global Poultry Vaccines market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Poultry Vaccines Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Broiler, Layer, Breeder)
  • 5.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 5.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Product Market Map
  • 5.3.1. By Application
  • 5.3.2. By Product
  • 5.3.3. By Disease Type
  • 5.3.4. By Region

6. North America Poultry Vaccines Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application (Broiler, Layer, Breeder)
  • 6.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 6.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Poultry Vaccines Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Disease Type
  • 6.3.2. Canada Poultry Vaccines Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Disease Type
  • 6.3.3. Mexico Poultry Vaccines Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Disease Type

7. Europe Poultry Vaccines Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application (Broiler, Layer, Breeder)
  • 7.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 7.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Poultry Vaccines Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Disease Type
  • 7.3.2. United Kingdom Poultry Vaccines Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Disease Type
  • 7.3.3. France Poultry Vaccines Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Disease Type
  • 7.3.4. Italy Poultry Vaccines Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Disease Type
  • 7.3.5. Spain Poultry Vaccines Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Disease Type

8. Asia-Pacific Poultry Vaccines Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application (Broiler, Layer, Breeder)
  • 8.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 8.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Poultry Vaccines Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Disease Type
  • 8.3.2. Japan Poultry Vaccines Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Disease Type
  • 8.3.3. India Poultry Vaccines Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Disease Type
  • 8.3.4. Australia Poultry Vaccines Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Disease Type
  • 8.3.5. South Korea Poultry Vaccines Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Disease Type

9. South America Poultry Vaccines Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application (Broiler, Layer, Breeder)
  • 9.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 9.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Poultry Vaccines Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Disease Type
  • 9.3.2. Argentina Poultry Vaccines Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Disease Type
  • 9.3.3. Colombia Poultry Vaccines Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Disease Type

10. Middle East and Africa Poultry Vaccines Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application (Broiler, Layer, Breeder)
  • 10.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 10.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Poultry Vaccines Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Disease Type
  • 10.3.2. Saudi Arabia Poultry Vaccines Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Disease Type
  • 10.3.3. UAE Poultry Vaccines Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Disease Type
  • 10.3.4. Kuwait Poultry Vaccines Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Application
      • 10.3.4.2.2. By Product
      • 10.3.4.2.3. By Disease Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Product Offerings
• 14.3. Recent Developments
• 14.4. Financials (As Reported)
• 14.5. Key Personnel
• 14.6. SWOT Analysis
  • 14.6.1. Boehringer Ingelheim GmbH
  • 14.6.2. Zoetis Inc
  • 14.6.3. Elanco LLC
  • 14.6.4. Intervet Inc
  • 14.6.5. Hester Biosciences Ltd
  • 14.6.6. Vaxxinova GmbH
  • 14.6.7. Venky's India Ltd
  • 14.6.8. Laboratorios Calier SA
  • 14.6.9. KM Biologics Co Ltd
  • 14.6.10. Phibro Animal Health Corp

15. Strategic Recommendations

16. About Us & Disclaimer